0001209191-22-037588.txt : 20220616
0001209191-22-037588.hdr.sgml : 20220616
20220616181922
ACCESSION NUMBER: 0001209191-22-037588
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220614
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhanji Muna
CENTRAL INDEX KEY: 0001846905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37766
FILM NUMBER: 221021765
MAIL ADDRESS:
STREET 1: C/O CYTOKINETICS, INCORPORATED
STREET 2: 280 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Intellia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001652130
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364785571
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-6200
MAIL ADDRESS:
STREET 1: 40 ERIE STREET
STREET 2: SUITE 130
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-14
0
0001652130
Intellia Therapeutics, Inc.
NTLA
0001846905
Bhanji Muna
C/O INTELLIA THERAPEUTICS, INC.
40 ERIE STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2022-06-14
4
A
0
2014
0.00
A
9968
D
Stock Option (right to buy)
38.49
2022-06-14
4
A
0
2980
0.00
A
2032-06-13
Common Stock
2980
2980
D
Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
This option was granted on June 14, 2022 with respect to 2,980 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
/s/James Basta, Attorney-In-Fact
2022-06-16